Beyond surgery: a multimodal framework for a pediatric metabolic and bariatric surgery program in a safety-net

Alaina P Vidmar1, Matthew J Martin2, Aimee G Kim3

  • 1Children's Hospital Los Angeles and Keck School of Medicine of USC, Department of Pediatrics, Center for Endocrinology, Diabetes and Metabolism, Los Angeles, California.

Insights

Developing a pediatric metabolic and bariatric surgery (MBS) program at a safety-net hospital improved access for underserved youth. This structured framework supports equitable and effective surgical care for severe pediatric obesity.

Area of Science:

  • Pediatric Surgery
  • Public Health
  • Healthcare Management

Background:

  • Severe pediatric obesity disproportionately impacts low-income and publicly insured youth.
  • Access to metabolic and bariatric surgery (MBS) is limited for these populations despite guidelines.
  • Safety-net hospitals face unique challenges in providing specialized care.

Purpose of the Study:

  • To describe the development of a pediatric MBS program within a safety-net children's hospital.
  • To outline a structured framework emphasizing interdisciplinary collaboration and equitable access.
  • To address barriers hindering surgical care for youth with severe obesity.

Main Methods:

  • Utilized real-world clinical vignettes to identify barriers like delayed care and medical complexity.
  • Implemented an integrated, adaptive approach involving multidisciplinary teams and ethical review.
  • Incorporated pre- and post-operative antiobesity medication and advocated for financial sustainability.

Main Results:

  • The developed model demonstrated improved access for historically excluded populations.
  • The program supports safe and effective surgical care for pediatric patients with severe obesity.
  • Early outcomes indicate the program's potential to reduce disparities in surgical access.

Conclusions:

  • The described framework can guide other institutions, including those with diverse payor mixes, in implementing pediatric MBS.
  • This model is particularly relevant for resource-limited or safety-net settings.
  • The approach promotes equitable access to essential surgical interventions for youth with severe obesity.
Abstract

Related Concept Videos

Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
174
Drug Dosing: Obese Patients01:21

Drug Dosing: Obese Patients

In the United States, obesity is a prominent concern. It is linked to heightened mortality rates due to increased occurrences of conditions such as hypertension, atherosclerosis, coronary artery disease, and diabetes compared to nonobese individuals. A patient is classified as obese if their actual body weight surpasses the ideal or desirable body weight by 20%, based on Metropolitan Life Insurance Company data. Ideal body weights consider average weights and heights for males and females...
198
Obesity01:24

Obesity

The Body Mass Index (BMI) is a numerical value derived from a person's weight and height, used to categorize individuals into weight ranges. It is calculated using the formula: weight in kilograms divided by height in meters squared. Obesity is a health condition characterized by excessive accumulation of adipose tissue that poses health risks, often diagnosed with a BMI ≥ 30. This excess fat storage occurs when surplus dietary calories are converted into triglycerides and stored in...
1.1K
Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion01:20

Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion

Drug metabolism, a critical process in the liver, involves two primary phases: Phase I reactions and Phase II conjugation. Obesity introduces significant alterations in this metabolic process, primarily due to fatty infiltration of the liver, leading to conditions such as nonalcoholic fatty liver disease (NAFLD). This condition can modify the activities of both Phase I and II enzymes, impacting how drugs are metabolized in obese patients.Phase I metabolism sees variable effects across...
159
Pharmacokinetics in Obese Patients: Drug Absorption and Distribution01:25

Pharmacokinetics in Obese Patients: Drug Absorption and Distribution

Obesity significantly alters the pharmacokinetic processes of drug absorption and distribution, presenting unique challenges in medical treatment. The increased fat tissue and decreased lean muscle in obese individuals can significantly affect how drugs are absorbed into the body and distributed across different tissues. This alteration can lead to variances in the effectiveness and safety of medications, necessitating adjustments in dosing or drug selection for obese patients.One notable...
221
Kidney Transplant II: Surgical Procedure01:26

Kidney Transplant II: Surgical Procedure

Preoperative ManagementThe primary goals of preoperative management in kidney transplantation are to optimize the patient’s metabolic state and prepare them for surgery through diet adjustments, necessary dialysis, and tailored medical treatment. This phase also involves comprehensive infection screening and patient education about the surgical procedure and postoperative care to improve outcomes and adherence.Medical ManagementA comprehensive evaluation is required for both the living...
279